Correvio Pharma Corp. Accounts Payable and Accrued Liabilities, Current
Correvio Pharma Corp. had Accounts Payable and Accrued Liabilities, Current of $11.29 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2020-04-30
- 2019-12-31: Accounts Payable and Accrued Liabilities, Current $11.29M.
- 2018-12-31: Accounts Payable and Accrued Liabilities, Current $9.40M.
- 2017-12-31: Accounts Payable and Accrued Liabilities, Current $7.70M.
- 2016-12-31: Accounts Payable and Accrued Liabilities, Current $8.02M.
| Period end | Accounts Payable and Accrued Liabilities, Current | Accounts Payable and Accrued Liabilities, Current as first filed |
|---|---|---|
| 2019-12-31 | $11.29M 20-F · filed 2020-04-30 | |
| 2018-12-31 | $9.40M 20-F · filed 2020-04-30 | |
| 2017-12-31 | $7.70M 40-F · filed 2019-03-13 | |
| 2016-12-31 | $8.02M 20-F · filed 2018-04-30 | |
| 2015-12-31 | $10.49M 40-F · filed 2017-03-29 | |
| 2014-12-31 | $13.06M 40-F · filed 2016-03-29 | $13.39M 40-F · filed 2015-03-27 |
| 2013-12-31 | $14.00M 40-F · filed 2015-03-27 | |
| 2012-12-31 | $4.43M 40-F/A · filed 2014-04-30 | |
| 2011-12-31 | $3.19M 20-F/A · filed 2013-04-18 | |
| 2010-12-31 | $5.71M 40-F/A · filed 2012-04-25 |